Gene Therapy Breakthrough Saves Siblings from Devastating Rare Disease
Ava's Early Health Challenges
From the moment Ava Langenhop was born, her parents noticed she was frequently ill. Hospital visits became a regular occurrence as she battled viral infections and constant ear troubles. Even minor injuries, like scraped knees, led to skin infections, adding to the family's worries. Her mother, Alicia, recalled how Ava was often labeled as 'just a sick baby.' These early health struggles set the stage for the family's long journey ahead.
A Family Beset by Illness
Ava's sibling, Olivia, faced similar health issues from birth, prompting Alicia and Jon Langenhop to seek answers. The constant cycle of illnesses and hospitalizations took a toll on the family, creating immense emotional and financial strain. Managing multiple sick children meant frequent doctor's visits and mounting medical bills, making the first few years particularly challenging for the Langenhops.
Unraveling the Mystery: LAD-1 Diagnosis
When Ava began experiencing severe gum inflammation and bleeding, a periodontist suggested testing for autoimmune diseases. This led the Langenhops to discover that Ava had LAD-1, a rare disorder affecting white blood cells. Unfortunately, Olivia was also diagnosed with the same condition, leaving the family grappling with a rare and serious health challenge. The diagnosis was a crucial turning point, clarifying the root cause of their children's persistent illnesses.
Facing the Odds: Bone Marrow Challenges
The standard treatment for LAD-1 is a bone marrow transplant, but finding a suitable donor proved difficult for the Langenhops. Neither parent was a match, and their newborn son, Landon, also tested positive for the disease, eliminating him as a potential donor. With no immediate family match available, the family turned to the national bone marrow donor registry, facing uncertain chances of finding a compatible donor.
A Ray of Hope: Clinical Trials
Desperate for a solution, the Langenhops learned about a clinical trial led by Rocket Pharmaceuticals. This innovative trial offered an investigational therapy that could allow patients to become their own stem cell donors, potentially increasing safety and effectiveness. Enrolling their children in the trial was a pivotal decision, providing them with a new avenue of hope amidst their ongoing struggles with LAD-1.
Recovery and a Bright Future
Five years after participating in the clinical trial, Ava, Olivia, and Landon are thriving. The therapy has successfully enabled their bodies to produce healthy immune cells, drastically reducing their need for hospital visits. Now active in sports and school, the children lead normal lives, offering their parents a newfound sense of relief and optimism. The Langenhop family's journey showcases the profound impact of medical advancements and the resilience of those battling rare diseases.
Conclusion
The Langenhop family's experience with LAD-1 highlights both the challenges of rare medical conditions and the hope brought by cutting-edge treatments. Their participation in a groundbreaking clinical trial not only transformed their lives but also contributed to the development of therapies that could benefit others in the future. Through perseverance and faith in medical innovation, the Langenhops have paved the way for a brighter, healthier future for their children and potentially countless others.
Read the full article here:
cbsnews.com